Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2020-04-29 Capital/Financing Update
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
Bone Therapeutics secures EUR 11.0 million financing
Capital/Financing Update Classification · 99% confidence The document is titled "Bone Therapeutics secures EUR 11.0 million financing" and details the structure of a recent fundraising effort, including bridge loans, equity private placement, and convertible bonds. This content directly relates to the company's capital structure and fundraising activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Call Transcript (CT). Since it is the primary announcement of the financing event itself, it is classified as CAP, not a Report Publication Announcement (RPA).
2020-04-29 English
Bone Therapeutics sécurise un financement de 11,0 millions d'euros
Capital/Financing Update Classification · 98% confidence The document is titled "Information réglementée" (Regulated Information) and announces that Bone Therapeutics has secured financing of 11.0 million euros through a combination of bridge loans, a private placement of shares, and convertible bonds. This content directly relates to the company's fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an Earnings Release (ER) as it focuses on financing, not operational results, nor is it a full Annual Report (10-K) or Interim Report (IR). Since it is a detailed announcement of the financing terms, it is classified as CAP rather than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2020-04-29 French
AR_2019_Full_EN_v11_Complete.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'FINANCIAL REPORT 2019' and contains a comprehensive table of contents covering the Board of Directors' report, corporate governance, remuneration, and full consolidated financial statements (IFRS) for the fiscal year ending 31 December 2019. It includes statutory auditor reports and detailed notes to the financial statements, which are the defining characteristics of an Annual Report (10-K equivalent for international entities). FY 2019
2020-04-29 English
AR_2019_Full_FR_v05_Complete.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'Rapport financier 2019' (Financial Report 2019) and contains a comprehensive table of contents covering the Board of Directors' report, consolidated financial statements, governance, and statutory accounts for the fiscal year ending December 31, 2019. It is a full-length annual report document, not an announcement or a summary. FY 2019
2020-04-29 French
PR_2020-04-03_BT_CB Denominator_EN_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is dated April 3, 2020, and is titled "Information on the total number of voting rights and shares." It explicitly states that the information is published in accordance with Article 15 of the Belgian Law of 2 May 2007 on the publication of major shareholdings in issuers whose shares are admitted to trading on regulated market. The core content details changes in the total number of shares, voting rights, capital, and potential shares following conversions and warrants. This directly relates to changes in significant share ownership or capital structure reporting requirements. While it involves share capital changes (suggesting SHA), the primary focus and regulatory citation point towards mandatory disclosure regarding voting rights and share counts, which is often captured under Major Shareholding Notification (MRQ) or general regulatory filings. Given the specific nature of reporting the total number of voting rights (the denominator for future filings) due to recent capital events (conversion of bonds), it aligns best with a Major Shareholding Notification (MRQ) or a general regulatory announcement. Since the document is a formal announcement detailing the new share count denominator resulting from a specific corporate action (bond conversion), and it is not a full financial report (10-K, IR) or a simple dividend notice (DIV), MRQ is the most specific fit for reporting changes in share structure that impact voting rights thresholds. However, since the document is a formal press release announcing the updated share count required by law, and it is not a specific form like a 13D/G (which MRQ often covers in the US context), classifying it as a general Regulatory Filing (RNS) is also plausible. Given the explicit focus on the 'Total number of shares with voting rights' and the reference to Belgian law on 'major shareholdings,' MRQ is the most precise fit among the provided options for this type of mandatory disclosure regarding share structure changes.
2020-04-03 English
PR_2020-04-03_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions" (Information relating to the total number of voting rights and shares) and is dated April 3, 2020. It explicitly details the change in the total number of shares and voting rights following the issuance of new shares due to the conversion of convertible bonds. This content directly relates to changes in the company's capital structure and share count, which aligns perfectly with the definition of a Share Issue/Capital Change announcement. The specific mention of the total number of voting rights (dénominateur) is a key indicator for filings related to share capital changes. Therefore, the appropriate code is SHA.
2020-04-03 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.